YARDLEY, Pa. and WOBURN, Mass., July 9, 2008 — Axendia Inc., a trusted advisor to Life-Science Executives on Business, Technology and Regulatory strategies, and CBI Research Inc., a provider of live and electronic conferences for senior-level executives in the pharmaceutical and biotech industries, today announced that Daniel R. Matlis President and Founder of Axendia, will chair CBI’s “3rd Annual Manufacturing Execution Systems for Life Sciences Congress” to be held on August 5 - 6, 2008 in Philadelphia, PA.
Over 500 pharmaceutical, biotech and medical device executives have benefited from the Manufacturing Execution Systems (MES) Conference. The 3rd Annual meeting convenes manufacturing decision-makers from the pharmaceutical, biotech and medical device communities.
“We are delighted to have Dan Matlis join us as Chairman of this year’s 3rd Annual MES for Life Sciences Congress,” commented Sharon Langan, Senior Program Manager for The Center for Business Intelligence. “This is the premier event for lean manufacturing and manufacturing execution systems in the pharmaceutical, biotech and medical device industries. Dan brings a very exciting perspective to this annual meeting, having worked extensively on projects spanning R&D, Engineering, Operations, Regulatory, Business Development and IT. He will add tremendous value to this important meeting,” added Langan.
“Life-Science Executives are facing some of the most difficult challenges ever encountered in the industry,” commented Daniel R. Matlis, President and Founder of Axendia. “This meeting offers an outstanding opportunity for industry executives to exchange ideas and solutions for next-generation manufacturing IT infrastructures,” Matlis added.
Constituents at the congress discuss current plant-level IT needs and discover the latest and best ways to implement a MES system for future success.
For detailed information about the 3rd Annual MES for Life Sciences Congress visit www.cbinet.com/mes
About Axendia Inc. A leading analysis firm focused on the Life-Sciences and Healthcare markets, the firm provides trusted advice to Life-Science Executives on Business, Regulatory and Technology issues. Axendia’s unique perspective is a result of our focus on the Life-Sciences and Healthcare markets and a unique blend of industry experience and strategic vision. This approach enables us to successfully identify, create and execute strategies which provide lasting business value for our clients. Additional information on Axendia’s can be found at www.Axendia.com
About CBI Research, Inc. Founded in 1994 in Massachusetts, CBI Research, Inc. is dedicated to developing market-driven, unbiased conferences in pharmaceuticals\biotech, medical devices, risk and insurance and managed care markets. CBI Research, Inc. offers conferences and summits that serve senior executives and government officials by providing a unique platform for highly focused content and presentation. As a delegate, speaker or sponsor, you receive timely information on the latest investment opportunities, business strategies, domestic and international regulatory issues, operations and applied technologies. Our events provide you with concrete, real life examples that you can begin to apply at your organization immediately for significant impact on costs and revenue. Plus, there are extensive opportunities for networking and discussion with senior policy and decision makers. Additional information on CBI Research can be found at www.cbinet.com